BioReference® offers scientific expertise and laboratory innovation in oncology, urology, and women’s health, with a focus on streamlining services to create a unique healthcare experience.

The laboratory is now at your fingertips with the HIPAA-compliant, secure BioReference® Patient Portal. Access your most recent laboratory reports, review previous results, pay your bill, and update your insurance information – all online.

BioReference offers thousands of tests ranging from routine blood screens to advanced genomic testing.

Visit one of our Laboratory patient service centers for adult and pediatric blood draw, 4Kscore testing and chain of custody drug screening.

BioReference® offers a multiplex test for flu and COVID-19 at the same time, using a single sample. This allows for more rapid diagnosis, conserves critical testing supplies, and provides surveillance for flu and COVID-19.

Our laboratory locations are built with patient comfort in mind. Find a lab, prepare for your visit or give us feedback on your most recent visit here.

Having trouble logging in? Please email us at patientportal@bioreference.com or call 888-279-0967.

BioReference ® has been working expeditiously to develop and offer test services that will yield high quality and accurate results, including a molecular test for helping with COVID-19 diagnosis and a serology test to help indicate possible COVID-19 exposure.

Why Choose BioReference? Connectivity. Insurance Coverage; Laboratory Analytics; Professional Support; Quality Control; Specialized Laboratories; Scientific Expertise and Innovation; Technology; Testimonials; Resources. Open an Account; Laboratory Tours; Test Directory; ICD-10 Search; Customer Satisfaction; Medical Coverage Policies; Additional ...

BioReference® offers a real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) assay, giving healthcare providers accurate and timely test results to ensure greater access to testing, promote earlier diagnosis and help limit the subsequent spread of infection.